glp-1 and dpp4 together glp 1 used receptor agonists or DPP-4 inhibitors: How to guide the clinician? How does sitagliptin work? DPP-4
Description
Studies done on obese mice show that GIP may help burn more energy and reduce fat build-up
Effects on weight In the SURPASS programme, change in weight was a prespecified secondary outcome
His approach goes beyond medication by integrating nutrition, exercise, and accountability to help patients achieve lasting results
By slowing the rate at which your stomach empties, GLP-1 helps you feel fuller for longer, reducing the urge to overeat
Another highlight was a symposium presenting findings from the groundbreaking FLOW trial, the first of its kind to focus on kidney outcomes with a GLP-1 receptor agonist
Once GLP-2 is deemed appropriate, patients receive their medication, administered as a once-weekly subcutaneous injection
